CXCL8 and prostate cancer: Similar findings have been observed in prostate cancer patients.[39] IL-8 belongs to the CXC chemokine superfamily that promotes inflammation by activating neutrophils and other immune cells, and can promote tumor angiogenesis.[40,41] In addition, RT induces the expression and activation of IL-1β and TGF-β.